Cost-Effectiveness of Vaccination Strategies to Control Future Mpox Outbreaks in England

xu-sheng zhang,Siwaporn Niyomsri,Sema Mandal,Hamish Mohammed,Miranda Mindlin,Bennet Dugbazah,Solomon Adjei,Andre Charlett,Jessica Edney,Elliot Sugars,Merav Kliner,Trish Mannes,Ellie Jewitt,Lorna Gilbert,Samihah Moazam,Claire Dewsnap,David Phillips,Gayatri Amirthalingam,Mary E Ramsay,Peter Vickerman,Josephine G Walker
DOI: https://doi.org/10.1101/2024.08.20.24312301
2024-08-20
Abstract:Background: In 2022, a global outbreak of mpox occurred among gay and bisexual men who have sex with men (GBMSM). In England, the outbreak was controlled through reductions in sexual risk behaviour and vaccination of high-risk GBMSM. However, mpox continues to circulate and so future outbreaks could occur. We evaluated the most cost-effective vaccination strategy to minimise future mpox outbreaks among GBMSM in England. Methods: A mathematical model of mpox transmission among GBMSM was developed to estimate the costs per quality-adjusted-life-year (QALY) gained for different vaccination strategies starting in 2024 (20-year time-horizon; 3.5% discount rate; willingness-to-pay threshold 20,000 pounds/QALY). The model was calibrated using English surveillance data from the 2022 outbreak and two community surveys. Reactive vaccination (only during outbreaks) and pre-emptive vaccination (continuous routine) strategies targeting high-risk GBMSM were compared to no vaccination. Baseline projections assumed vaccine effectiveness of 78%/89% for 5/10 years with 1/2 doses at 160 pounds/dose. Costs were estimated for case management, vaccination and public health responses (PHR) during an outbreak. Findings: All vaccination strategies reduced costs and gained QALYs compared to no vaccination. Continuous pre-emptive vaccination (daily rate 41 doses) was most cost-effective, saving 39.56 million pounds and gaining 547.6 QALYs over 20-years. Threshold analyses suggested vaccination of high-risk GBMSM is cost-effective if the vaccine costs < 701 pounds/dose. Pre-emptive vaccination remains the optimal strategy across numerous sensitivity analyses, but the optimal vaccination rate can vary. Reactive vaccination only becomes more cost-effective when PHR costs are not included. Interpretation: Pre-emptive vaccination of high-risk GBMSM is a cost-saving strategy to prevent future mpox outbreaks.
Infectious Diseases (except HIV/AIDS)
What problem does this paper attempt to address?